Skip to Main Content

Author Details

Russell A Wilke
University of South Dakota Sanford School of Medicine
1989
114
39
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36898195Rural Land Management and Kidney Health.S D Med2023
37150941Drug-Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program.Clin Pharmacol Ther2023
35034348SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care.Clin Pharmacol Ther2022
36893027Cytochrome P450 2D6 Genotyping for Post-Operative Opioids.S D Med2022
35152405The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.Clin Pharmacol Ther2022
34343516Air, Land, and Sea: Gene-Environment Interaction in Chronic Disease.Am J Med2021
34575630Potential Use of Pharmacogenetics to Reduce Drug-Induced Syndrome of Inappropriate Antidiuretic Hormone (SIADH).J Pers Med2021
34449991Relative Contribution of Genetic and Environmental Factors in CKD.S D Med2021
32723143<i>CYP2C19</i> genotype-guided antiplatelet therapy: promises and pitfalls.Pharmacogenomics2020
30679510Learning from Longitudinal Data in Electronic Health Record and Genetic Data to Improve Cardiovascular Event Prediction.Sci Rep2019
31453774Implementation of wide-scale pharmacogenetic testing in primary care.Pharmacogenomics2019
30983508<i>CYP2C19</i> genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitors.Pharmacogenomics2019
30998912Chronic Kidney Disease in Agricultural Communities.Am J Med2019
29102571Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.JACC Cardiovasc Interv2018
29634825Fracking and Climate Change-Reply.JAMA2018
29703846LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.Circulation2018
29280137Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.Clin Pharmacol Ther2018
28532511Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.BMC Med Genomics2017
28294551The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.Clin Transl Sci2017
29334439Pharmacogenetics - The Year in Review.S D Med2017
29049815Potential Health Implications Related to Fracking.JAMA2017
28813770Point-Counterpoint: SLCO1B1 Genotyping for Statins.S D Med2017
27023676Navigating pleiotropy in precision medicine: pharmacogenes from trauma to behavioral health.Pharmacogenomics2016
27587472Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.J Med Genet2016
27320715The Reply.Am J Med2016
26709912PharmGKB summary: very important pharmacogene information for RYR1.Pharmacogenet Genomics2016
26031886Integration of Genomics in Primary Care.Am J Med2015
24096969Characterization of statin dose response in electronic medical records.Clin Pharmacol Ther2014
25717410Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins.AMIA Jt Summits Transl Sci Proc2014
25493567Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting.Pharmacogenomics2014
25352737Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci.Mol Vis2014
25350695Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.Nat Commun2014
24918167The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.Clin Pharmacol Ther2014
24297552Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.Pac Symp Biocomput2014
21912424CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.Pharmacogenomics J2013
23829686Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.Hum Genomics2013
23876492Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care.Circ Cardiovasc Genet2013
23995691A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.Nature2013
23651022Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.Pharmacogenomics2013
23748922A common functional promoter variant links CNR1 gene expression to HDL cholesterol level.Nat Commun2013
23267855The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.Clin Pharmacol Ther2013
22060278Lack of association between polymorphisms in the prostaglandin F2α receptor and solute carrier organic anion transporter family 2A1 genes and intraocular pressure response to prostaglandin analogs.Ophthalmic Genet2012
23067351High density GWAS for LDL cholesterol in African Americans using electronic medical records reveals a strong protective variant in APOE.Clin Transl Sci2012
22739144Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.Clin Pharmacol Ther2012
22534870Electronic medical records as a tool in clinical pharmacology: opportunities and challenges.Clin Pharmacol Ther2012
22462750Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.Pharmacogenomics2012
22588608Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.Clin Pharmacol Ther2012
22617227The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.Clin Pharmacol Ther2012
22567136CNR1 genotype influences HDL-cholesterol response to change in dietary fat intake.PLoS One2012
22319176Importance of multi-modal approaches to effectively identify cataract cases from electronic health records.J Am Med Inform Assoc2012
  • 1 - 50 of 114

Recommended Authors

Moneeza K Siddiqui
University of Dundee, Ninewells Hospital and Medical School
Career Start Year 2016
Number of shared co-authors 34
Nihal El Rouby
Department of Pharmacy Practice and Administrative Sciences, University of Cincinnati
Career Start Year 2013
Number of shared co-authors 45
Megan M Shuey
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 19
Omri Gottesman
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 75
Jessica Minnier
Louis Stokes Cleveland VA Medical Center Cleveland
Career Start Year 2010
Number of shared co-authors 6
James S Floyd
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 35
Nathan E Wineinger
Scripps Research Translational Institute, The Scripps Research Institute
Career Start Year 2008
Number of shared co-authors 1
Jason H Karnes
Vanderbilt University Medical Center
Career Start Year 2007
Number of shared co-authors 55
Ian B Stanaway
Kidney Research Institute and Division of Nephrology, University of Washington
Career Start Year 2006
Number of shared co-authors 39
Michael Steffens
Federal Institute for Drugs and Medical Devices (BfArM)
Career Start Year 2005
Number of shared co-authors 7
Changchun Xie
University of Cincinnati
Career Start Year 2004
Number of shared co-authors 2
Scott J Hebbring
Marshfield Clinic Research Institute
Career Start Year 2003
Number of shared co-authors 51
Thomas J Urban
Eshelman School of Pharmacy, University of North Carolina
Career Start Year 2003
Number of shared co-authors 13
Sara L Van Driest
National Institutes of Health
Career Start Year 2002
Number of shared co-authors 77
Noura S Abul-Husn
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Career Start Year 2002
Number of shared co-authors 46
Alison A Motsinger-Reif
National Institute of Environmental Health Sciences
Career Start Year 2002
Number of shared co-authors 30
Xin-Qun Wang
University of Virginia Health System
Career Start Year 2001
Number of shared co-authors 10
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 11
Jeanette J McCarthy
Fabric Genomics Inc.
Career Start Year 2000
Number of shared co-authors 4
Linnea M Baudhuin
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 4
Ulrich Broeckel
Medical College of Wisconsin
Career Start Year 1998
Number of shared co-authors 60
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Career Start Year 1998
Number of shared co-authors 57
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 22
Brinda K Rana
University of California
Career Start Year 1996
Number of shared co-authors 0
Hemant K Tiwari
University of Alabama at Birmingham
Career Start Year 1995
Number of shared co-authors 43
Deanna L Kroetz
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 27
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 9
Peter Kraft
Harvard T. H. Chan School of Public Health
Career Start Year 1988
Number of shared co-authors 55
Nicholas J Schork
University of California San Diego
Career Start Year 1987
Number of shared co-authors 33
Vincent Mooser
McGill University
Career Start Year 1987
Number of shared co-authors 33

Collaborators

Catherine A McCarty
University of Minnesota Medical School, 1035 University Drive duluth
Co-authored papers 29
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 21
Joshua C Denny
Vanderbilt University
Co-authored papers 21
Ronald M Krauss
Co-authored papers 17
QiPing Feng
Vanderbilt University Medical Center
Co-authored papers 15
Richard L Berg
Marshfield Clinic Research Institute
Co-authored papers 13
Marylyn D Ritchie
Center for Systems Genomics, Pennsylvania State University, University Park
Co-authored papers 12
Peggy L Peissig
Center for Precision Medicine Research, Marshfield Clinic Research Institute
Co-authored papers 10
Dana C Crawford
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 9
Wei-Qi Wei
Vanderbilt University Medical Center
Co-authored papers 8
Andrea H Ramirez
Vanderbilt University Medical Center
Co-authored papers 6
Jerome I Rotter
Co-authored papers 6
Deepak Voora
Durham VA Healthcare System and Duke University
Co-authored papers 6
Gail P Jarvik
University of Washington Medical Center
Co-authored papers 6
James G Linneman
Marshfield Clinic Research Institute
Co-authored papers 6
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 5
Rhonda M Cooper-DeHoff
College of Medicine, University of Florida
Co-authored papers 5
Charles M Stein
Vanderbilt University School of Medicine
Co-authored papers 5
Luke V Rasmussen
Northwestern University Feinberg School of Medicine
Co-authored papers 5
Rongling Li
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 5
Deborah A Nickerson
University of Washington
Co-authored papers 5
Hua Xu
Yale University
Co-authored papers 5
Iftikhar J Kullo
Mayo Clinic
Co-authored papers 5
Kathleen M Giacomini
University of California San Francisco
Co-authored papers 4
Monique Hayes
Feinberg School of Medicine, Northwestern University
Co-authored papers 4
Xiaohui Li
Co-authored papers 4
Rebecca L Zuvich
Center for Human Genetics Research, Vanderbilt University School of Medicine
Co-authored papers 4
Daniel R Masys
University of Washington School of Medicine.
Co-authored papers 4
Paul M Ridker
Co-authored papers 4
Victoria M Pratt
Indiana University School of Medicine
Co-authored papers 4
Release 1.2